Terms: = Thyroid cancer AND TRA AND Treatment
17 results:
1. Pharmacokinetics/Pharmacodynamics of Dabrafenib and trametinib for Redifferentiation and treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated thyroid cancer.
Balakirouchenane D; Seban R; Groussin L; Puszkiel A; Cottereau AS; Clerc J; Vidal M; Goldwasser F; Arrondeau J; Blanchet B; Huillard O
Thyroid; 2023 Nov; 33(11):1327-1338. PubMed ID: 37725566
[No Abstract] [Full Text] [Related]
2. De-escalated Therapy Omitting Anthracyclines for Stage I HER2-positive Breast cancer: A Retrospective Observational Study.
Nakamoto S; Ikeda M; Kubo S; Yamamoto M; Yamashita T
In Vivo; 2020; 34(6):3713-3718. PubMed ID: 33144488
[TBL] [Abstract] [Full Text] [Related]
3. Multicentric study applying the european laryngological society classification of benign laryngotracheal stenosis in adults treated by tracheal or cricotracheal resection and anastomosis.
Fiz I; Monnier P; Koelmel JC; Di Dio D; Fiz F; Missale F; Piazza C; Peretti G; Sittel C
Laryngoscope; 2020 Jul; 130(7):1640-1645. PubMed ID: 31508817
[TBL] [Abstract] [Full Text] [Related]
4. thyroid Patient Salivary Radioiodine transit and Dysfunction Assessment Using Chewing Gums.
Okkalides D
Cancer Biother Radiopharm; 2016 Nov; 31(9):330-341. PubMed ID: 27831763
[TBL] [Abstract] [Full Text] [Related]
5. The Result of Multiple I-131 treatments on the Effective Half-Life of Retained Radioactivity in Patients Ablated for Differentiated thyroid cancer: Possible Evidence for thyroid Remnant Function Impairment.
Okkalides D
Cancer Biother Radiopharm; 2016 Mar; 31(2):58-64. PubMed ID: 26986816
[TBL] [Abstract] [Full Text] [Related]
6. thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario.
Campennì A; Giovanella L; Pignata SA; Violi MA; Siracusa M; Alibrandi A; Moleti M; Amato E; Ruggeri RM; Vermiglio F; Baldari S
Nucl Med Commun; 2015 Nov; 36(11):1100-6. PubMed ID: 26302462
[TBL] [Abstract] [Full Text] [Related]
7. Sorafenib sensitizes solid tumors to Apo2L/traIL and Apo2L/traIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis.
Abdulghani J; Allen JE; Dicker DT; Liu YY; Goldenberg D; Smith CD; Humphreys R; El-Deiry WS
PLoS One; 2013; 8(9):e75414. PubMed ID: 24086526
[TBL] [Abstract] [Full Text] [Related]
8. Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancer.
Welsh L; Powell C; Pratt B; Harrington K; Nutting C; Harmer C; Newbold K
J Clin Endocrinol Metab; 2013 May; 98(5):1819-25. PubMed ID: 23493434
[TBL] [Abstract] [Full Text] [Related]
9. Regulation of sodium iodide symporter gene expression by Rac1/p38β mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cells.
Kogai T; Liu YY; Mody K; Shamsian DV; Brent GA
J Biol Chem; 2012 Jan; 287(5):3292-300. PubMed ID: 22157753
[TBL] [Abstract] [Full Text] [Related]
10. Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells.
Ohashi E; Kogai T; Kagechika H; Brent GA
Cancer Res; 2009 Apr; 69(8):3443-50. PubMed ID: 19351850
[TBL] [Abstract] [Full Text] [Related]
11. Retinoic acid stimulation of the sodium/iodide symporter in MCF-7 breast cancer cells is mediated by the insulin growth factor-I/phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase signaling pathways.
Kogai T; Ohashi E; Jacobs MS; Sajid-Crockett S; Fisher ML; Kanamoto Y; Brent GA
J Clin Endocrinol Metab; 2008 May; 93(5):1884-92. PubMed ID: 18319322
[TBL] [Abstract] [Full Text] [Related]
12. [Recombinant human TSH use in differentiated thyroid cancer].
Graf H; Paz-Filho G
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):806-12. PubMed ID: 17891244
[TBL] [Abstract] [Full Text] [Related]
13. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
[TBL] [Abstract] [Full Text] [Related]
14. transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells.
Dentice M; Luongo C; Elefante A; Romino R; Ambrosio R; Vitale M; Rossi G; Fenzi G; Salvatore D
Mol Cell Biol; 2004 Sep; 24(18):7863-77. PubMed ID: 15340050
[TBL] [Abstract] [Full Text] [Related]
15. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.
Kogai T; Schultz JJ; Johnson LS; Huang M; Brent GA
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8519-24. PubMed ID: 10890895
[TBL] [Abstract] [Full Text] [Related]
16. Involvement of nuclear steroid/thyroid/retinoid receptors and of protein kinases in the regulation of growth and of c-erbB and retinoic acid receptor expression in MCF-7 breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Breast Cancer Res Treat; 1999 Nov; 58(2):171-81. PubMed ID: 10674883
[TBL] [Abstract] [Full Text] [Related]
17. Evidence of a retinoid signaling alteration involving the activator protein 1 complex in tumorigenic human bronchial epithelial cells and non-small cell lung cancer cells.
Lee HY; Dawson MI; Claret FX; Chen JD; Walsh GL; Hong WK; Kurie JM
Cell Growth Differ; 1997 Mar; 8(3):283-91. PubMed ID: 9056670
[TBL] [Abstract] [Full Text] [Related]
